Elizabeth Oyekan, PharmD, FCSHP, CPHQ

Pharma Insights

Big Data Analytics in Health Care and Drug Therapy Management—Opportunities and Considerations

04/20/2022

Marissa Baker-Wagner, MPH

Ronaé McLin, MPH

Dr Okeyan and colleagues discuss key areas where big data analytics are being leveraged in health care, the implications to payer and pharma stakeholders, and key considerations for success.

Dr Okeyan and colleagues ...

04/20/2022

Journal of Clinical Pathways

Pharma Insights

The Patient and Consumer Experience—The Core and Progress Duality for Successful and Sustainable Transformation

03/16/2022

Elizabeth Oyekan, PharmD, FCSHP, CPHQ

Cynthia Miller, MD, MPH

Elizabeth Oyekan, PharmD, FCSHP, CPHQ, and colleagues propose a vision for the future of the patient/consumer experience to serve as a blueprint for organizations to develop and implement a strategy that is both effective and in alignment...

Elizabeth Oyekan, PharmD, FCSHP,...

03/16/2022

Journal of Clinical Pathways

Pharma Insights

Impact of NextGen Access Decision Makers on Health Care Services and Therapies

09/23/2021

Elizabeth Oyekan, PharmD, FCSHP, CPHQ

Dominic Galante, MD

Elizabeth Oyekan, PharmD, and Dominic Galante, MD, discuss next generation access decision makers and value-based care in the midst of the pandemic and beyond.

Elizabeth Oyekan, PharmD, and...

09/23/2021

Journal of Clinical Pathways

Pharma Insights

Value Transformation: Observations on Performance Periods 1-5 Evaluation Report of the Oncology Care Model

06/21/2021

Maureen Hennessey, PhD, CPCC, CPHQ

Elizabeth Oyekan, PharmD, FCSHP, CPHQ

Maureen Hennessey, PhD, CPCC, CPHQ, discusses Medicare spending as well as other performance measures related to the patient experience, management of depression and pain, emergency department and hospital use, end-of-life care, and...

Maureen Hennessey, PhD, CPCC,...

06/21/2021

Journal of Clinical Pathways

Pharma Insights

Where Incentives Align (or Don’t) Among Health Care Stakeholders and How They Are Evolving

03/16/2020

Avi Mamidi, PharmD

Elizabeth Oyekan, PharmD, FCSHP, CPHQ

Jeremy Schafer, PharmD, MBA

Larry Blandford, PharmD—Column Editor

The goal of all health care stakeholders—payers, providers, and health systems—is to lower health care costs and improve patient health outcomes, yet the path to getting to this goal remains questionable, partially...

The...

03/16/2020

Journal of Clinical Pathways